CRL vs ORCL · rev $2.00B vs P/E 31, rev $67.36B
Charles River Laboratories (CRL) versus Oracle Corporation (ORCL) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Michael D. Sicilia.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
CRL currently screens at market cap $7.78B. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
Not investment advice. Open the CRL and ORCL stock pages for the full models.
Not investment advice.